128 related articles for article (PubMed ID: 2492697)
1. Restriction of HIV-1 replication in promonocytic cells: a role for IFN-alpha.
Macé K; Duc Dodon M; Gazzolo L
Virology; 1989 Feb; 168(2):399-405. PubMed ID: 2492697
[TBL] [Abstract][Full Text] [Related]
2. Interferon-regulated viral replication in chronically HIV1-infected promonocytic U937 cells.
Macé K; Gazzolo L
Res Virol; 1991; 142(2-3):213-20. PubMed ID: 1716778
[TBL] [Abstract][Full Text] [Related]
3. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
Gendelman HE; Baca L; Turpin JA; Kalter DC; Hansen BD; Orenstein JM; Friedman RM; Meltzer MS
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1045-9. PubMed ID: 2121192
[TBL] [Abstract][Full Text] [Related]
4. Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production.
Locardi C; Petrini C; Boccoli G; Testa U; Dieffenbach C; Buttò S; Belardelli F
J Virol; 1990 Dec; 64(12):5874-82. PubMed ID: 1700829
[TBL] [Abstract][Full Text] [Related]
5. Regulation of HIV1 replication in promonocytic U937 cells.
Gazzolo L; Macé K
Res Virol; 1990; 141(2):259-65. PubMed ID: 2345813
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.
Puddu P; Locardi C; Sestili P; Varano F; Petrini C; Modesti A; Masuelli L; Gresser I; Belardelli F
J Virol; 1991 May; 65(5):2245-53. PubMed ID: 1901915
[TBL] [Abstract][Full Text] [Related]
7. Enhanced resistance to HIV-1 replication in U937 cells stably transfected with the human IFN-beta gene behind an MHC promoter fragment.
Mace K; Seif I; Anjard C; De Maeyer-Guignard J; Dodon MD; Gazzolo L; De Maeyer E
J Immunol; 1991 Nov; 147(10):3553-9. PubMed ID: 1940355
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.
Gendelman HE; Baca LM; Turpin J; Kalter DC; Hansen B; Orenstein JM; Dieffenbach CW; Friedman RM; Meltzer MS
J Immunol; 1990 Oct; 145(8):2669-76. PubMed ID: 1976701
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
11. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.
Kornbluth RS; Oh PS; Munis JR; Cleveland PH; Richman DD
J Exp Med; 1989 Mar; 169(3):1137-51. PubMed ID: 2466937
[TBL] [Abstract][Full Text] [Related]
12. [Studies on susceptibility of promonocytic cell line U937-derived subclones to HIV-1 infection and apoptosis induction].
Kameoka M
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):489-508. PubMed ID: 8809573
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 replication by daunorubicin.
Filion LG; Logan D; Gaudreault R; Izaguirre CA
Clin Invest Med; 1993 Oct; 16(5):339-47. PubMed ID: 8261687
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
Smith MS; Thresher RJ; Pagano JS
Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
[TBL] [Abstract][Full Text] [Related]
15. The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells.
Alfano M; Vallanti G; Biswas P; Bovolenta C; Vicenzi E; Mantelli B; Pushkarsky T; Rappuoli R; Lazzarin A; Bukrinsky M; Poli G
J Immunol; 2001 Feb; 166(3):1863-70. PubMed ID: 11160233
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester.
Clapham PR; Weiss RA; Dalgleish AG; Exley M; Whitby D; Hogg N
Virology; 1987 May; 158(1):44-51. PubMed ID: 3107214
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units.
Cory JM; Ohlsson-Wilhelm BM; Steck ME; Smithgall MD; Rozday V; Eyster ME; Rapp F
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):97-106. PubMed ID: 2497763
[TBL] [Abstract][Full Text] [Related]
18. Targeting HIV-1 to Fc gamma R on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells.
Howell AL; Guyre PM; You K; Fanger MW
J Leukoc Biol; 1994 Mar; 55(3):385-91. PubMed ID: 8120455
[TBL] [Abstract][Full Text] [Related]
19. Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.
Vendrame D; Sourisseau M; Perrin V; Schwartz O; Mammano F
J Virol; 2009 Oct; 83(20):10527-37. PubMed ID: 19706714
[TBL] [Abstract][Full Text] [Related]
20. Tropism of human immunodeficiency virus 1 isolates for H9 cells and U937 cells.
Cory JM; Ohlsson-Wilhelm BM; Rapp F
Intervirology; 1990; 31(2-4):101-8. PubMed ID: 2373608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
